IRIS
NGUYEN, THI PHUONG NHUNG
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 544
AS - Asia 10
SA - Sud America 4
NA - Nord America 1
Totale 559
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 544
CN - Cina 5
BR - Brasile 3
VN - Vietnam 3
ID - Indonesia 2
CL - Cile 1
US - Stati Uniti d'America 1
Totale 559
Salva come PNG Salva come JPEG
Città #
Genoa 380
Vado Ligure 124
Rapallo 22
Genova 15
Beijing 3
Bordighera 3
Hanoi 2
Barra do Corda 1
Campos dos Goytacazes 1
Estación Colina 1
Ho Chi Minh City 1
Kisaran 1
Medan 1
Philadelphia 1
Pontal do Paraná 1
Totale 557
Salva come PNG Salva come JPEG
Nome #
EFFECTS OF PHARMACOLOGICAL GPR17 MODULATION IN THE SOD1G93A MOUSE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS 109
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases 72
Montelukast improves disease outcome in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity 64
Insights into Human-Induced Pluripotent Stem Cell-Derived Astrocytes in Neurodegenerative Disorders 55
Effects of the GPR17 antagonist montelukast on oligodendrocyte dysfunction and disease outcome in the SOD1G93A mouse model of ALS 52
A repurposing approach to improve disease outcome in SOD1G93A mice by counteracting oligodendrocyte dysfunction and neuroinflammation 49
A repurposing approach to delay disease progression in SOD1G93A mice by counteracting oligodendrocyte dysfunction 44
In-vivo treatment with the GPR17 antagonist montelukast ameliorated the lifespan and delayed the disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 31
Montelukast improves disease progression in the female SOD1G93A mouse model of ALS by restoring oligodendrocyte maturation and counteracting altered glial reactivity 29
In-vivo treatment with the GPR17 antagonist montelukast improves lifespan and delays disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 26
Pharmacological blockade of the P2Y-like GPR17 receptor with montelukast delays disease progression by counteracting oligodendrocyte dysfunction in the SOD1G93A mouse model of amyotrophic lateral sclerosis 25
Montelukast improves disease outcomes in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity 25
null 1
Totale 582
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.532
article - articoli 859
book - libri 0
conference - conferenze 1.387
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.778
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202223 0 0 1 0 0 0 0 2 8 3 6 3
2022/202351 3 0 0 0 0 1 4 2 6 11 18 6
2023/202476 6 4 0 8 4 22 9 6 1 2 8 6
2024/2025284 15 18 9 36 31 31 14 54 2 5 41 28
2025/2026148 65 9 32 42 0 0 0 0 0 0 0 0
Totale 582